FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283688974> ?p ?o ?g. }

• W4283688974 endingPage "11" @default.
• W4283688974 startingPage "1" @default.
• W4283688974 abstract "Coronavirus disease 2019 (COVID-19) has been a global threat that pushes healthcare to its limits. Hypertension is one of the most common risk factors for cardiovascular complications in COVID-19 and is strongly associated with disease severity and mortality. To date, clinical mechanisms by which hypertension leads to increased risk in COVID-19 are still unclear. Furthermore, additional factors might increase these risks, such as the consideration of age and sex, which are of interest when in search of personalized treatments for hypertensive COVID-19 patients.We conducted a retrospective cohort study of 543 COVID-19 patients in seven provinces of China to examine the epidemiological and clinical characteristics of COVID-19 in this population and to determine risk factors of hypertensive COVID-19 patients. We also used univariable and multivariable logistic regression methods to explore the risk factors associated with hypertensive COVID-19 patients in different age and sex subgroups.Among the enrolled COVID-19 patients, the median age was 47 years (interquartile range (IQR) 34.0-57.0), and 99 patients (18.23%) were over 60 years old. With regard to comorbidities, 91 patients (16.75%) were diagnosed with hypertension, followed by diabetes, coronary disease, and cerebrovascular disease. Of the hypertensive COVID-19 patients, 51 (56.04%) were male. Multivariable analysis showed that old age, comorbid diabetes or coronary heart disease on admission, increased D-dimer, increased glucose, and decreased lymphocyte count were independent risk factors associated with hypertensive COVID-19 patients. Elevated total bilirubin (odds ratio [OR]: 1.014, 95% confidence interval [CI]: 0.23-1.05; p = 0.043) and triglycerides (OR: 1.173, 95% CI: 0.049-1.617; p = 0.007) were found to be associated with elderly hypertensive COVID-19 patients. In addition, we found that decreased lymphocytes, basophil, high-density lipoprotein, and increased fibrinogen and creatinine were related to a higher risk of disease severity in male patients. The most common abnormal clinical findings pertaining to female hypertensive COVID-19 patients were hemoglobin, total bile acid, total protein, and low-density lipoprotein.Factors associated with increased risk of hypertensive COVID-19 patients were identified. Results to the different age and sex subgroups in our study will allow for better possible personalized care and also provide new insights into specific risk stratification, disease management, and treatment strategies for COVID-19 patients with hypertension in the future." @default.
• W4283688974 created "2022-06-30" @default.
• W4283688974 creator A5008017308 @default.
• W4283688974 creator A5013202913 @default.
• W4283688974 creator A5013259692 @default.
• W4283688974 creator A5015444218 @default.
• W4283688974 creator A5022951375 @default.
• W4283688974 creator A5034253292 @default.
• W4283688974 creator A5039832836 @default.
• W4283688974 creator A5040678479 @default.
• W4283688974 creator A5040701683 @default.
• W4283688974 creator A5043256966 @default.
• W4283688974 creator A5043821001 @default.
• W4283688974 creator A5044059518 @default.
• W4283688974 creator A5051700748 @default.
• W4283688974 creator A5053608602 @default.
• W4283688974 creator A5061828492 @default.
• W4283688974 creator A5064530138 @default.
• W4283688974 creator A5071485078 @default.
• W4283688974 creator A5074244488 @default.
• W4283688974 creator A5076328008 @default.
• W4283688974 creator A5079280300 @default.
• W4283688974 creator A5085156142 @default.
• W4283688974 creator A5086161890 @default.
• W4283688974 creator A5086672036 @default.
• W4283688974 creator A5091181915 @default.
• W4283688974 date "2022-06-28" @default.
• W4283688974 modified "2023-09-22" @default.
• W4283688974 title "Retrospective Study of Aging and Sex-Specific Risk Factors of COVID-19 with Hypertension in China" @default.
• W4283688974 cites W1521607954 @default.
• W4283688974 cites W1987631879 @default.
• W4283688974 cites W2009410829 @default.
• W4283688974 cites W2033199439 @default.
• W4283688974 cites W2074935860 @default.
• W4283688974 cites W2079671805 @default.
• W4283688974 cites W2092133813 @default.
• W4283688974 cites W2126125759 @default.
• W4283688974 cites W2134270369 @default.
• W4283688974 cites W2147507671 @default.
• W4283688974 cites W2155729092 @default.
• W4283688974 cites W2906310637 @default.
• W4283688974 cites W2907575819 @default.
• W4283688974 cites W2942819007 @default.
• W4283688974 cites W3001195213 @default.
• W4283688974 cites W3003109697 @default.
• W4283688974 cites W3009885589 @default.
• W4283688974 cites W3010336234 @default.
• W4283688974 cites W3010507954 @default.
• W4283688974 cites W3010848803 @default.
• W4283688974 cites W3013125498 @default.
• W4283688974 cites W3013959692 @default.
• W4283688974 cites W3016126001 @default.
• W4283688974 cites W3016265209 @default.
• W4283688974 cites W3016535995 @default.
• W4283688974 cites W3017183898 @default.
• W4283688974 cites W3019039411 @default.
• W4283688974 cites W3035029466 @default.
• W4283688974 cites W3038063455 @default.
• W4283688974 cites W3038215148 @default.
• W4283688974 cites W3038474713 @default.
• W4283688974 cites W3082751011 @default.
• W4283688974 cites W3108625642 @default.
• W4283688974 cites W3158636901 @default.
• W4283688974 cites W3213895211 @default.
• W4283688974 cites W4214834868 @default.
• W4283688974 cites W4224037604 @default.
• W4283688974 cites W4230714752 @default.
• W4283688974 cites W4285719527 @default.
• W4283688974 cites W4287914098 @default.
• W4283688974 cites W4313341533 @default.
• W4283688974 cites W4362197812 @default.
• W4283688974 cites W80087804 @default.
• W4283688974 doi "https://doi.org/10.1155/2022/5978314" @default.
• W4283688974 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35846735" @default.
• W4283688974 hasPublicationYear "2022" @default.
• W4283688974 type Work @default.
• W4283688974 citedByCount "2" @default.
• W4283688974 countsByYear W42836889742022 @default.
• W4283688974 countsByYear W42836889742023 @default.
• W4283688974 crossrefType "journal-article" @default.
• W4283688974 hasAuthorship W4283688974A5008017308 @default.
• W4283688974 hasAuthorship W4283688974A5013202913 @default.
• W4283688974 hasAuthorship W4283688974A5013259692 @default.
• W4283688974 hasAuthorship W4283688974A5015444218 @default.
• W4283688974 hasAuthorship W4283688974A5022951375 @default.
• W4283688974 hasAuthorship W4283688974A5034253292 @default.
• W4283688974 hasAuthorship W4283688974A5039832836 @default.
• W4283688974 hasAuthorship W4283688974A5040678479 @default.
• W4283688974 hasAuthorship W4283688974A5040701683 @default.
• W4283688974 hasAuthorship W4283688974A5043256966 @default.
• W4283688974 hasAuthorship W4283688974A5043821001 @default.
• W4283688974 hasAuthorship W4283688974A5044059518 @default.
• W4283688974 hasAuthorship W4283688974A5051700748 @default.
• W4283688974 hasAuthorship W4283688974A5053608602 @default.
• W4283688974 hasAuthorship W4283688974A5061828492 @default.
• W4283688974 hasAuthorship W4283688974A5064530138 @default.
• W4283688974 hasAuthorship W4283688974A5071485078 @default.
• W4283688974 hasAuthorship W4283688974A5074244488 @default.

• next